Literature DB >> 26786217

The extrapulmonary dissemination of tuberculosis: A meta-analysis.

Andrew Scott Webster1, Wayne Xavier Shandera2.   

Abstract

BACKGROUND AND
OBJECTIVE: The epidemiology of the forty percent of tuberculosis patients who present with disseminated and/or extrapulmonary disease is in need of further study. Further study of such dissemination using published data from international indices may provide data which assist with control of tuberculosis.
METHODS: For each clinical or epidemiologic factor studied, summary odds ratios and corresponding 95% confidence intervals were calculated showing associations between such factors and documented extrapulmonary dissemination of tuberculosis.
RESULTS: Eighteen studies fulfilled criteria for study of the clinical factors and nine for the cytokine studies. Significant factors associated with a greater risk of extrapulmonary dissemination were female gender (summary odds ratio, 1.92 (95% confidence intervals, 1.72-2.13), I-squared 86.9), age under 45 (1.37, 1.18-1.60, 63.7), and as well the absence of smoking, drinking and diabetes but not HIV infection (1.10, 0.91-1.32, 80.5). Among cytokines, the macrophage receptor protein P2X7 was associated most strongly associated with extrapulmonary dissemination of tuberculosis (2.28, 0.88-5.90, 92.9).
CONCLUSION: Young age, female gender, and the macrophage purinergic receptor protein P2X7 were major factors associated with extrapulmonary dissemination of tuberculosis. Published by Elsevier Ltd.

Entities:  

Keywords:  Cytokines; Dissemination; Extrapulmonary; Meta-analysis; Mycobacteria; Tuberculosis

Year:  2014        PMID: 26786217     DOI: 10.1016/j.ijmyco.2014.01.003

Source DB:  PubMed          Journal:  Int J Mycobacteriol        ISSN: 2212-5531


  6 in total

1.  Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Mandy Yao; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2021-01-15

Review 2.  Xpert® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance.

Authors:  Mikashmi Kohli; Ian Schiller; Nandini Dendukuri; Keertan Dheda; Claudia M Denkinger; Samuel G Schumacher; Karen R Steingart
Journal:  Cochrane Database Syst Rev       Date:  2018-08-27

Review 3.  P2RX7 at the Host-Pathogen Interface of Infectious Diseases.

Authors:  Alexandra Y Soare; Tracey L Freeman; Alice K Min; Hagerah S Malik; Elizabeth O Osota; Talia H Swartz
Journal:  Microbiol Mol Biol Rev       Date:  2021-01-13       Impact factor: 11.056

4.  Uncommon testicular localization of Disseminated TB: a case report from Mozambique.

Authors:  Evangelina Inacio Namburete; Francesco Di Gennaro; Cleide Jose Maria; Davide Fiore Bavaro; Gaetano Brindicci; Rossana Lattanzio; Damiano Pizzol; Laura Monno; Annalisa Saracino
Journal:  New Microbiol       Date:  2019-07-15       Impact factor: 1.383

5.  Estimating the impact of tuberculosis anatomical classification on treatment outcomes: A patient and surveillance perspective analysis.

Authors:  Otavio T Ranzani; Laura C Rodrigues; Eliseu A Waldman; Carlos R R Carvalho
Journal:  PLoS One       Date:  2017-11-22       Impact factor: 3.240

6.  COMPLICATED LUMBAR TUBERCULOUS SPONDYLODISCITIS IN DISSEMINATED TUBERCULOSIS, TREATED USING A NON-CONVENTIONAL ANTERIOR SUPPORT SYSTEM FOR HYDROSTATIC DISTRACTION: A CASE REPORT.

Authors:  Alex Oliveira de Araujo; Thiago Queiroz Soares; Alessandro Gonzalez Torelli; Allan Hiroshi de Araujo Ono; Raphael Martus Marcon; Alexandre Fogaça Cristante; Tarcísio Eloy Pessoa de Barros
Journal:  Acta Ortop Bras       Date:  2018       Impact factor: 0.513

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.